BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kachare SD, Liner KR, Vohra NA, Zervos EE, Fitzgerald TL. A Modified Duodenal Neuroendocrine Tumor Staging Schema Better Defines the Risk of Lymph Node Metastasis and Disease-free Survival. The American Surgeon 2014;80:821-6. [DOI: 10.1177/000313481408000836] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Iwasaki T, Nara S, Kishi Y, Esaki M, Shimada K, Hiraoka N. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature. Langenbecks Arch Surg 2017;402:925-33. [DOI: 10.1007/s00423-016-1537-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
2 Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Spolverato G, Maithel SK, Pawlik TM. Surgical outcomes of patients with duodenal vs pancreatic neuroendocrine tumors following pancreatoduodenectomy. J Surg Oncol 2020;122:442-9. [PMID: 32470159 DOI: 10.1002/jso.25978] [Reference Citation Analysis]
3 Schmocker RK, Wright MJ, Ding D, Javed AA, Cameron JL, Lafaro K, Burns WR, He J, Wolfgang CL, Burkhart RA. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin. J Surg Oncol 2021;123:416-24. [PMID: 33125737 DOI: 10.1002/jso.26285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Broecker JS, Ethun CG, Postlewait LM, Le N, Mcinnis M, Russell MC, Sullivan P, Kooby DA, Staley CA, Maithel SK, Cardona K. Colon and Rectal Neuroendocrine Tumors: Are They Really One Disease? A Single-Institution Experience over 15 Years. The American Surgeon 2018;84:717-26. [DOI: 10.1177/000313481808400525] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Goretzki PE, Mogl MT, Akca A, Pratschke J. Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract. Rev Endocr Metab Disord 2018;19:169-78. [DOI: 10.1007/s11154-018-9469-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Bergsland EK, Woltering EA, Rindi G, O’dorisio TM, Schilsky RL, Liu EH, Kim MK, Nakakura EK, Reidy-lagunes DL, Strosberg JR, Tang LH, Vinik AI, Wang Y, Asare EA, Brierley JD, Bushnell DL, Jensen RT, Pommier RF, Wolin EM, Wong RKS, Klimstra DS. Neuroendocrine Tumors of the Duodenum and Ampulla of Vater. In: Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR, editors. AJCC Cancer Staging Manual. Cham: Springer International Publishing; 2017. pp. 361-73. [DOI: 10.1007/978-3-319-40618-3_30] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
7 Fitzgerald TL, Mosquera C, Lea CS, Mcmullen M. Primary Site Predicts Grade for Gastroenteropancreatic Neuroendocrine Tumors. The American Surgeon 2017;83:799-803. [DOI: 10.1177/000313481708300741] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
8 Fitzgerald TL, Mosquera C, Vora HS, Vohra NA, Zervos EE. Indications for Surgical Resection in Low-Grade Pancreatic Neuroendocrine Tumors. The American Surgeon 2016;82:737-42. [DOI: 10.1177/000313481608200834] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhang X, Wu X, Tsilimigras DI, Poultsides G, Rocha F, Abbott DE, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM; other members of the US Neuroendocrine Tumor Study Group. Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined. J Surg Oncol 2019;120:1302-10. [DOI: 10.1002/jso.25753] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
10 Mosquera C, Fitzgerald TL, Vora H, Grzybowski M. Novel nomogram combining depth of invasion and size can accurately predict the risk for regional nodal metastases for appendiceal neuroendocrine tumors (A-NET). J Surg Oncol 2017;116:651-7. [PMID: 28608390 DOI: 10.1002/jso.24714] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]